Vimarsana
Biggest News Aggregation in the World

Page 3 - Peripheral Intervention News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peripheral Intervention. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peripheral Intervention Today - Breaking & Trending Today

Concept Medical granted Investigational Device Exemption (IDE) approval for their Magic Touch Sirolimus Coated Balloon for the treatment of Below the Knee (BTK) Arterial Disease - Vimarsana News

Concept Medical granted Investigational Device Exemption (IDE) approval for their Magic Touch Sirolimus Coated Balloon for the treatment of Below the Knee (BTK) Arterial Disease

/PRNewswire/ -- Concept Medical Inc. (CMI), on 9th February 2023, received the Investigational Device Exemption (IDE) from the US FDA, for its Magic Touch...

Business News | Concept Medical Granted Investigational Device Exemption (IDE) Approval for Their Magic Touch Sirolimus Coated Balloon for the Treatment of Below the Knee (BTK) Arterial Disease - Vimarsana News

Business News | Concept Medical Granted Investigational Device Exemption (IDE) Approval for Their Magic Touch Sirolimus Coated Balloon for the Treatment of Below the Knee (BTK) Arterial Disease

Get latest articles and stories on Business at LatestLY. Concept Medical Inc. (CMI), on 9th February 2023, received the Investigational Device Exemption (IDE) from the US FDA, for its Magic Touch Sirolimus Coated Balloon. Business News | Concept Medical Granted Investigational Device Exemption (IDE) Approval for Their Magic Touch Sirolimus Coated Balloon for the Treatment of Below the Knee (BTK) Arterial Disease.

BD Reports First Quarter Fiscal 2023 Financial Results - Vimarsana News

BD Reports First Quarter Fiscal 2023 Financial Results

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its first quarter of...

BD Reports Fourth Quarter and Full Year Fiscal 2022 Financial Results - Vimarsana News

BD Reports Fourth Quarter and Full Year Fiscal 2022 Financial Results

Execution of BD 2025 Strategy Driving Consistent Durable Growth Q4 revenue from continuing operations of $4.8 billion decreased 1.8% as reported and increased...

BD REPORTS THIRD QUARTER FISCAL 2022 FINANCIAL RESULTS - Vimarsana News

BD REPORTS THIRD QUARTER FISCAL 2022 FINANCIAL RESULTS

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its third quarter of...